These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15557383)

  • 21. Images in cardiology. The traumatic effect of balloon dilatation on neointimal hyperplasia: what we did not see before optical coherence tomography.
    Picchi A; Micheli A; Limbruno U
    Heart; 2011 Feb; 97(3):265-6. PubMed ID: 21036803
    [No Abstract]   [Full Text] [Related]  

  • 22. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial.
    Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Staico R; Feres F; Centemero M; Tanajura LF; Abizaid A; Pinto I; Maldonado G; Seixas A; Costa MA; Paes A; Mintz GS; Sousa JE
    Circulation; 2004 Feb; 109(7):861-6. PubMed ID: 14757690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
    Finn AV; Nakazawa G; Kolodgie FD; Virmani R
    JACC Cardiovasc Interv; 2009 Apr; 2(4):300-2. PubMed ID: 19463440
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.
    Cheneau E; Pichard AD; Satler LF; Suddath WO; Weissman NJ; Waksman R
    Am J Cardiol; 2005 May; 95(10):1240-2. PubMed ID: 15878001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial intravascular ultrasound comparison of the extent and distribution of intimal hyperplasia six months after stent implantation for de novo versus in-stent restenosis lesions.
    Escolar E; Mintz GS; Canos D; Cheneau E; Pichard AD; Satler LF; Kent KM; Waksman R; Weissman NJ
    Am J Cardiol; 2005 Oct; 96(7):897-900. PubMed ID: 16188512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
    Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
    Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mysteries behind stent struts.
    Waksman R
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):254-6. PubMed ID: 15858790
    [No Abstract]   [Full Text] [Related]  

  • 31. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
    Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
    J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neointimal tissue proliferation after coronary stent implantation without predilatation].
    Martí V; Romeo I; Kozak F; García-Picart J; Guiteras P; García-Arriaga JC; Puntí J; Augé JM
    Rev Esp Cardiol; 2005 Sep; 58(9):1045-53. PubMed ID: 16185617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of measuring coronary lumen density with multi-slice computed tomography to detect in-stent restenosis.
    Kitagawa T; Yamamoto H; Horiguchi J; Hirai N; Fujii T; Ito K; Kohno N
    Int J Cardiol; 2008 Feb; 124(2):239-43. PubMed ID: 17360050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lumen overdilation improves outcome after brachytherapy of in-stent restenosis.
    Witkowski A; Kalińczuk Ł; Chmielak Z; Pregowski J; Łyczek J; Kawczyńska M; Bulski W; Kulik A; Pszona S; Kepka C; Przyłuski J; Owczarczyk J; Ruzyłło W
    Cardiovasc Revasc Med; 2006; 7(4):202-7. PubMed ID: 17174864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
    Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F
    J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.